| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000001041 |
| Receipt No. | R000001248 |
| Official scientific title of the study | LOWER NORMAL PRESSURE GLAUCOMA STUDY |
| Date of disclosure of the study information | 2008/02/23 |
| Last modified on | 2017/02/27 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | LOWER NORMAL PRESSURE GLAUCOMA STUDY
|
|
| Title of the study (Brief title) | LNPGS | |
| Region |
|
|
| Condition | ||
| Condition | Glaucoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clear up many clinical features in the Normal Pressure Glaucoma (NPG) patients (intraocular pressure is less than 15 mmHg) during the time course. To examine the eye-specific and systemic risk factors regarding about the visual field progression. The prospective study (about 165 patients and three observation years) in domestic multi facilities.
|
| Basic objectives2 | Others |
| Basic objectives -Others | Observasional study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Progression of visual field defect and/or optic disc damage |
| Key secondary outcomes | Campimetry results with Humphrey automated perimeter,disc hemorrhage and parameter of HRT II and GDx VCC |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Primary open-angle glaucoma patients to fullfill the following criterias.
The intraocular pressure (IOP) lowering drugs are not used or after four weeks or more have passed since the IOP drugs were discontinued, the IOP is 15 mmHg or less excluding one measurement at five times or more measured on different days within six months. The tonometry mesurements should be always less than 21 mmHg. The level of visual field defect: MD of both eyes is more excellent than that of -15 dB. |
|||
| Key exclusion criteria | An equivalent sphered value is -9.0D less than or +9.0D or more.
Best corrected visual acuity is less than 0.8. Anamnestic history of any eye surgerys including laser therapy. Eyes with cataract that influences the visual field. The patinets who have taken orally hypotensive agents or agents about protection of tissue damege. The patinets who have troubles such as hepertension (over 160/90) and diabetes mellitus. |
|||
| Target sample size | 165 | |||
| Research contact person | |
| Name of lead principal investigator | Araie Makoto |
| Organization | Director, Kanto Central Hospital
|
| Division name | Department of Ophthalmology |
| Address | 6-25-1, Kamiyouga, Setagaya-ku, 158-8531, Tokyo, Japan |
| TEL | 03-3429-1171 |
| araie-tky@umin.net | |
| Public contact | |
| Name of contact person | Sakata Rei |
| Organization | The University of Tokyo Hospital |
| Division name | Department of Ophthalmology |
| Address | 7-3-1 Hongo, Bunkyoku, Tokyo, 113-8655 Japan |
| TEL | 03-3815-5411 |
| Homepage URL | |
| reisakata-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Japan Glaucoma Society |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Glaucoma Society |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | prospective study of background factors for normal tension glaucoma patinets. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000001248 |